Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 10/2007

01-12-2007 | Original Paper

A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores

Auteurs: Susan Yount, Marcy List, Hongyan Du, Kathleen Yost, Rita Bode, Bruce Brockstein, Athanassios Argiris, Everett Vokes, Ezra E. W. Cohen, Bruce Campbell, Veronica Valenzuela, Jacquelyn George, Robyn Egan, Jessica Chen, David Meddis, David Cella

Gepubliceerd in: Quality of Life Research | Uitgave 10/2007

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Objective

To evaluate the impact of administration context (embedded versus stand-alone) on the reliability and validity of the FACT Head and Neck Symptom Index (FHNSI).

Methods

Ninety-eight patients with head and neck cancer were randomized to one of two assessment conditions to evaluate the FHNSI’s context (items administered embedded within the FACT-H&N or as stand-alone scale) and order of administration in the battery.

Results

Planned comparisons on the item and scale levels revealed no systematic order or context differences. The embedded and stand-alone versions of the FHNSI showed high internal consistency (Cronbach's alpha 0.79–0.87). Correlations were high between the FHNSI versions and the physical and functional well-being scales of the FACT-H&N (0.70–0.84) and measures of pain intensity (−0.73, −0.74) and depression (−0.71, −0.74); moderate to large with the Performance Status Scale for Head and Neck subscales (PSS-HN; 0.46–0.71); and low with an anxiety measure (0.30, 0.34). Both FHNSI versions differentiated patients grouped by performance status (p < .0001, p < .0001) and global rating of change (p < .0001, p < 0.01). The FHNSI's minimally important difference range was 3–4 points.

Conclusion

The FHNSI is a reliable and valid symptom index, which can be administered alone or scored using items embedded within the FACT-H&N.
vorige artikel Quality of life of adults with workplace exacerbation of asthma
volgende artikel Response shift due to diagnosis and primary treatment of localized prostate cancer: a then-test and a vignette study
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., et al. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85, 365–376.PubMedCrossRef
2.
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Lloyd, S., Linn, E., et al. (1993). The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure. Journal of Clinical Oncology, 11, 570–579.PubMed
3.
Schipper, H., Clinch, J., McMurray, A., & Levitt, M. (1984). Measuring the quality of life of cancer patients: The Functional Living Index-Cancer: Development and validation. Journal of Clinical Oncology, 2, 472–483.PubMed
4.
Taylor, K. M., Macdonald, K. G., Bezak, A., Ng, P., & DePetrillo, A. D. (1996). Physicians’ perspective on quality of life: An exploratory study of oncologists. Quality of Life Research, 5, 5–14.PubMedCrossRef
5.
Morris, J., Perez, D., & McNoe, B. (1998). The use of quality of life data in clinical practice. Quality of Life Research, 7, 85–91.PubMedCrossRef
6.
Browman, G. P. (1999). Science, language, intuition, and the many meanings of quality of life. Journal of Clinical Oncology, 17, 1651–1653.PubMed
7.
Gill, T. M., & Feinstein, A. R. (1994). A critical appraisal of the quality of quality-of-life measurements. Journal of the American Medical Association, 272, 619–626.PubMedCrossRef
8.
List, M. A., Ritter-Sterr, C. A., Baker, T. M., et al. (1996). Longitudinal assessment of quality of life in laryngeal cancer patients. Head & Neck, 18, 1–10.CrossRef
9.
Bjordal, K., Kaasa, S., & Mastekaasa, A. (1994). Quality of life in patients treated for head and neck cancer: A follow-up study 7 to 11 years after radiotherapy. International Journal of Radiation Oncology, Biology, Physics, 28, 847–856.PubMed
10.
Shaha, A. R., & Strong, E. W. (1995). Cancer of the head and neck. In G. P. Murphy, W. Lawrence, & R. E. Lenhard (Eds.), Clinical oncology (2nd ed., pp. 251–268). Atlanta, GA: The American Cancer Society, Inc.
11.
Vokes, E. E., Kies, M. S., Haraf, D. J., Stenson, K., List, M. A., Humerickhouse, R., et al. (2000). Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. Journal of Clinical Oncology, 18, 1652–1661.PubMed
12.
Cella, D., Paul, D., Yount, S., Winn, R., Chang, C. H., Banik, et al. (2003). What are the most important symptom targets when treating advanced cancer? A survey of providers in the National Comprehensive Cancer Network (NCCN). Cancer Investigation, 4, 526–535.
13.
Leidy, N. K., Legro, M., Schmier, J., et al. (2000). Does order of administration affect subject response to generic and condition-specific measures of health related quality of life? Quality of Life Research, 9, 337.
14.
Cheung, Y.-B., Wong, L.-C., Tay, M.-H., Toh, C.-K., Koo, W.-H., Epstein, R., et al. (2004). Order effects in the assessment of quality of life in cancer patients. Quality of Life Research, 13, 1217–1223.PubMedCrossRef
15.
Cheung, Y.-B., Lim, C., Goh, C., Thumboo, J., & Wee, J. (2005). Order effects: A randomized study of three major cancer-specific quality of life instruments. Health and Quality of Life Outcomes, 3, 37.PubMedCrossRef
16.
Karnofsky, D. A., & Burchenal, J. H. (1949). The clinical evaluation of chemotherapeutic agents in cancer. In C. M. Macleod (Ed.), Evaluation of chemotherapeutic agents (pp. 199–205). New York: Columbia University Press.
17.
Zubrod, C., Schneiderman, M., Frei, E., III, Brindley, C., Gold, G. L., Shnider, B., et al. (1960). Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene. Journal of Chronic Diseases, 11, 7–33.CrossRef
18.
List, M. A., D’Antonio, L. L., Cella, D. F., Siston, A., Mumby, P., Haraf, D., et al. (1996). The Performance Status Scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck Scale. A study of utility and validity. Cancer, 77, 2294–2301.PubMedCrossRef
19.
Rogers, S. N., Courneya, K. S., Robins, K. T., Malone, J., Seiz, A., Koch, L., et al. (2006). Physical activity and quality of life in head and neck cancer survivors. Supportive Care in Cancer, 14, 1012–1019.PubMedCrossRef
20.
Epstein, J. B., Beaumont, J. L., Gwede, C. K., Murphy, B., Garden, A. S., Meredith, R., et al. (2007). Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire. Cancer, 109, 1914–1922.PubMedCrossRef
21.
Smith, G. I., Yeo, D., Clark, J., Choy, E. T., Gao, K., Oates, J., et al. (2006). Measures of health-related quality of life and functional status in survivors of oral cavity cancer who have had defects reconstructed with radial forearm free flaps. British Journal of Oral & Maxillofacial Surgery, 44, 187–192.CrossRef
22.
Ringash, J., Bezjak, A., O’Sullivan, B., & Redelmeier, D. A. (2004). Interpreting differences in quality of life: The FACT-H & N in laryngeal cancer patients. Quality of Life Research, 13, 725–733.PubMedCrossRef
23.
List, M. A., Ritter-Sterr, C., & Lansky, S. B. (1990). A performance status scale for head and neck cancer patients. Cancer, 66, 564–569.PubMedCrossRef
24.
Fung, K., Teknos, T. N., Vandenberg, C. D., Lyden, T. H., Bradford, C. R., & Hogikyan, N. D. (2007). Prevention of wound complications following salvage laryngectomy using free vascularized tissue. Head & Neck, 29, 425–430.CrossRef
25.
Meyer, T. K., Kuhn, J. C., Campbell, B. H., Marbella, A. M., Myers, K. B., Layde, P. M., et al. (2004). Speech intelligibility and quality of life in head and neck cancer survivors. Laryngoscope, 114, 1977–1981.PubMedCrossRef
26.
Campbell, B. H., Spinelli, K., Marbella, A. M., Myers, K. B., Kuhn, J. C., & Layde, P. M. (2004). Aspiration, weight loss, and quality of life in head and neck cancer survivors. Archives of Otolaryngology—Head & Neck Surgery, 130, 1100–1103.CrossRef
27.
Cleeland, C. S., & Ryan, K. M. (1994). Pain assessment: Global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore, 23, 129–138.PubMed
28.
Passik, S. D., Kirsch, K. L., Donaghy, K. B., & Portenoy, R. K. (2006). Pain and aberrant drug-related behaviors in medically ill patients with and without histories of substance abuse. The Clinical Journal of Pain, 22, 173–181.PubMedCrossRef
29.
McQuellon, R. P., Thaler, H. T., Cella, D., & Moore, D. H. (2006). Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study. Gynecologic Oncology, 101, 296–304.PubMedCrossRef
30.
Miaskowski, C., Dodd, M., West, C., Paul, S. M., Schumacher, K., Tripathy, D., et al. (2007). The use of responder analysis to identify differences in patient outcomes following a self-care intervention to improve cancer pain management. Pain, 129, 55–63.PubMedCrossRef
31.
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.CrossRef
32.
Rogers, S. N., Rajlawat, B., Goru, J., Lowe, D., & Humphris, G. M. (2006). Comparison of the domains of anxiety and mood of the University of Washington head and neck cancer questionnaire (UW-QOL-4) with the CES-D and HADS. Head & Neck, 28, 697–704.CrossRef
33.
Katz, M. R., Kopek, N., Waldron, J., Devins, G. M., & Tomlinson, G. (2004). Screening for depression in head and neck cancer. Psycho-Oncology, 13, 269–280.PubMedCrossRef
34.
Derks, W., Leeuy, J. R. J., Hordijk, G. J., & Winnubst, J. A. M. (2005). Differences in coping style and locus of control between older and younger patients with head and neck cancer. Clinical Otolaryngology, 30, 186–192.PubMedCrossRef
35.
List, M. A., Mumby, P., Haraf, D., Siston, A., Mick, R., MacCracken, E., et al. (1997). Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Quality of Life Research, 6, 273–284.CrossRef
36.
Zigmond, A. S., & Snaith, R. P. (1983). The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica, 67, 361–370.PubMedCrossRef
37.
Hammerlid, E., Ahlner-Elmqvist, M., Bjordal, K., Biorklund, A., Evensen, J., Boysen, M., et al. (1999). A prospective multicentre study in Sweden and Norway of mental distress and psychiatric morbidity in head and neck cancer patients. British Journal of Cancer, 80, 766–774.PubMedCrossRef
38.
Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H., et al. (2000). Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer, 88, 2817–2823.PubMedCrossRef
39.
Crowne, D. P., & Marlowe, D. (1960). A new scale of social desirability independent of psychopathology. Journal of Consulting Psychology, 24, 349–354.PubMedCrossRef
40.
Jaeschke, R., Singer, J., & Guyatt, G. (1989). Measurement of health status: Ascertaining the minimal clinically important difference. Controlled Clinical Trials, 10, 407–415.PubMedCrossRef
41.
Cella, D., Yount, S., Du, H., Dhanda, R., Gondek, K., Langefeld, K., et al. (2006). Development and validation of the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI). The Journal of Supportive Oncology, 4, 191–199.PubMed
42.
Cella, D., Hahn, E. A., & Dineen, K. (2002). Meaningful change in cancer-specific quality of life scores: Differences between improvement and worsening. Quality of Life Research, 11, 207–221.PubMedCrossRef
43.
Doyle, C., Crump, M., Pintilie, M., & Oza, A. M. (2001). Does palliative chemotherapy palliate? Evaluation of expectations, outcomes, and costs in women receiving chemotherapy for advanced ovarian cancer. Journal of Clinical Oncology, 19, 1266–1274.PubMed
44.
Serdula, M. K., Mokdad, A. H., Pamuk, E. R., Williamson, D. F., & Byers, T. (1995). Effects of question order on estimates of the prevalence of attempted weight loss. American Journal of Epidemiology, 42, 64–67.
45.
Jensen, P. S., Watanabe, H. K., & Richters, J. E. (1999). Who’s up first? Testing for order effects in structured interviews using a counterbalanced experimental design. Journal of Abnormal Child Psychology, 27, 436–439.
46.
Bowling, A. (2005). Mode of questionnaire administration can have serious effects on data quality. Journal of Public Health, 27, 281–291.PubMedCrossRef
47.
Ingham, J. M., & Portenoy, R. K. (1996). Symptom assessment. Hematology Oncology Clinics of North America, 10, 21–39.CrossRef
48.
Chang, V., Hwang, S., Feuerman, M., & Kasimis, B. S. (2000). Symptom and quality of life surveys of medical oncology patients at a Veterans Affairs Medical Center: A role for symptom assessment. Cancer, 88, 1175–1183.PubMedCrossRef
Metagegevens
Titel
A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores
Auteurs
Susan Yount
Marcy List
Hongyan Du
Kathleen Yost
Rita Bode
Bruce Brockstein
Athanassios Argiris
Everett Vokes
Ezra E. W. Cohen
Bruce Campbell
Veronica Valenzuela
Jacquelyn George
Robyn Egan
Jessica Chen
David Meddis
David Cella
Publicatiedatum
01-12-2007
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 10/2007
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-007-9270-9

Andere artikelen Uitgave 10/2007

Quality of Life Research 10/2007 Naar de uitgave

OriginalPaper

Respondent satisfaction regarding SF-36 and EQ-5D, and patients’ perspectives concerning health outcome assessment within routine health care

Original Paper

Marker states and a health state prompt provide modest improvements in the reliability and validity of the standard gamble and rating scale in prostate cancer patients

OriginalPaper

Long-term health-related quality of life in survivors of meningococcal septic shock in childhood and their parents

OriginalPaper

Cluster analysis: a useful technique to identify elderly cardiac patients at risk for poor quality of life

OriginalPaper

Impact of smoking on asthma symptoms, healthcare resource use, and quality of life outcomes in adults with persistent asthma

OriginalPaper

Chronical illness and maternity: life conditions, quality of life and coping in women with multiple sclerosis